Advertisement

Topics

Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid?

06:30 EDT 21 Jun 2017 | Xconomy

A 2014 report provided a stark frame of reference for the challenge of fighting Alzheimer’s disease, showing that 99.6 percent of all drugs in the field had failed in one way or another. Led by Jeffrey Cummings, director of the Cleveland Clinic’s Lou Ruvo Center for Brain Health, the same authors recently published a new […]

Original Article: Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid?

NEXT ARTICLE

More From BioPortfolio on "Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid?"

Advertisement
Quick Search
Advertisement
Advertisement